Drug Enforcement Administration – Federal Register Recent Federal Regulation Documents

Results 1 - 50 of 4,521
Importer of Controlled Substances Application: SpecGx LLC
Document Number: 2025-05060
Type: Notice
Date: 2025-03-26
Agency: Drug Enforcement Administration, Department of Justice
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Document Number: 2025-05056
Type: Notice
Date: 2025-03-26
Agency: Drug Enforcement Administration, Department of Justice
Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC
Document Number: 2025-05055
Type: Notice
Date: 2025-03-26
Agency: Drug Enforcement Administration, Department of Justice
Pharmaron Manufacturing Services (US), LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Document Number: 2025-05054
Type: Notice
Date: 2025-03-26
Agency: Drug Enforcement Administration, Department of Justice
Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Maridose LLC (I)
Document Number: 2025-05065
Type: Notice
Date: 2025-03-26
Agency: Drug Enforcement Administration, Department of Justice
Maridose, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Document Number: 2025-05007
Type: Rule
Date: 2025-03-24
Agency: Drug Enforcement Administration, Department of Justice, Department of Health and Human Services
In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were originally scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services delayed the effective dates of these two final rules to March 21, 2025, by issuing a final rule; delay of effective dates and request for comments in the February 19, 2025, issue of the Federal Register. The Drug Enforcement Administration received 32 comments in response to the request for public comments regarding the delayed effective date. Considering these comments, the Department of Justice wishes to further postpone the effective dates for the purpose of further reviewing any questions of fact, law, and policy that the rules may raise. Therefore, the Drug Enforcement Administration and the Department of Health and Human Services will delay the effective date of the two final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients" to December 31, 2025.
Margaret Sprague, M.D.; Decision and Order
Document Number: 2025-04754
Type: Notice
Date: 2025-03-20
Agency: Drug Enforcement Administration, Department of Justice
William Needham, N.P.; Decision and Order
Document Number: 2025-04753
Type: Notice
Date: 2025-03-20
Agency: Drug Enforcement Administration, Department of Justice
Rachel Jackson, P.A.; Decision and Order
Document Number: 2025-04752
Type: Notice
Date: 2025-03-20
Agency: Drug Enforcement Administration, Department of Justice
Linwood A. Starks, D.V.M.; Decision and Order
Document Number: 2025-04746
Type: Notice
Date: 2025-03-20
Agency: Drug Enforcement Administration, Department of Justice
Hazem Barmada, M.D.; Decision and Order
Document Number: 2025-04768
Type: Notice
Date: 2025-03-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
Document Number: 2025-04285
Type: Notice
Date: 2025-03-17
Agency: Drug Enforcement Administration, Department of Justice
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC
Document Number: 2025-04284
Type: Notice
Date: 2025-03-17
Agency: Drug Enforcement Administration, Department of Justice
Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Document Number: 2025-04046
Type: Notice
Date: 2025-03-13
Agency: Drug Enforcement Administration, Department of Justice
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
Document Number: 2025-04045
Type: Notice
Date: 2025-03-13
Agency: Drug Enforcement Administration, Department of Justice
Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
Document Number: 2025-04044
Type: Notice
Date: 2025-03-13
Agency: Drug Enforcement Administration, Department of Justice
Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Meridian Medical Technologies, LLC
Document Number: 2025-04043
Type: Notice
Date: 2025-03-13
Agency: Drug Enforcement Administration, Department of Justice
Meridian Medical Technologies, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Stepan Company
Document Number: 2025-03766
Type: Notice
Date: 2025-03-10
Agency: Drug Enforcement Administration, Department of Justice
Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: LTS Therapy Systems, LLC
Document Number: 2025-03648
Type: Notice
Date: 2025-03-07
Agency: Drug Enforcement Administration, Department of Justice
LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
Document Number: 2025-03636
Type: Notice
Date: 2025-03-06
Agency: Drug Enforcement Administration, Department of Justice
Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Indivior Inc.
Document Number: 2025-03635
Type: Notice
Date: 2025-03-06
Agency: Drug Enforcement Administration, Department of Justice
Indivior Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC
Document Number: 2025-03170
Type: Notice
Date: 2025-02-27
Agency: Drug Enforcement Administration, Department of Justice
Groff Hemplex LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma
Document Number: 2025-03062
Type: Notice
Date: 2025-02-26
Agency: Drug Enforcement Administration, Department of Justice
S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2025-03061
Type: Notice
Date: 2025-02-26
Agency: Drug Enforcement Administration, Department of Justice
Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Sharp Clinical Services, LLC
Document Number: 2025-03060
Type: Notice
Date: 2025-02-26
Agency: Drug Enforcement Administration, Department of Justice
Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Jason Weakley R.N., A.P.R.N.; Decision and Order
Document Number: 2025-02936
Type: Notice
Date: 2025-02-21
Agency: Drug Enforcement Administration, Department of Justice
Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Document Number: 2025-02793
Type: Rule
Date: 2025-02-19
Agency: Drug Enforcement Administration, Department of Justice, Department of Health and Human Services
In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services are delaying the effective dates of these two final rules to March 21, 2025, and are soliciting public comments specifically regarding this delayed effective date.
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Document Number: 2025-02740
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Document Number: 2025-02739
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Document Number: 2025-02738
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Lonza Tampa, LLC
Document Number: 2025-02737
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Document Number: 2025-02733
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.
Document Number: 2025-02732
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Mylan Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Document Number: 2025-02731
Type: Notice
Date: 2025-02-18
Agency: Drug Enforcement Administration, Department of Justice
Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Yogesh Patel, M.D.; Decision and Order
Document Number: 2025-02629
Type: Notice
Date: 2025-02-14
Agency: Drug Enforcement Administration, Department of Justice
Robert L. Carter, D.D.S.; Decision and Order
Document Number: 2025-02622
Type: Notice
Date: 2025-02-14
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Purisys, LLC
Document Number: 2025-02600
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
Document Number: 2025-02599
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Veranova, L.P.
Document Number: 2025-02597
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Maridose LLC
Document Number: 2025-02596
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
Maridose LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: University of Kentucky Cannabis Center
Document Number: 2025-02595
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Mylan Inc.
Document Number: 2025-02594
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Document Number: 2025-02593
Type: Notice
Date: 2025-02-13
Agency: Drug Enforcement Administration, Department of Justice
Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
David Bockoff, M.D.; Decision and Order
Document Number: 2025-02421
Type: Notice
Date: 2025-02-10
Agency: Drug Enforcement Administration, Department of Justice
Massoud Amini, M.D.; Decision and Order
Document Number: 2025-02342
Type: Notice
Date: 2025-02-07
Agency: Drug Enforcement Administration, Department of Justice
James T. Craig, D.D.S.; Decision and Order
Document Number: 2025-02341
Type: Notice
Date: 2025-02-07
Agency: Drug Enforcement Administration, Department of Justice
Herold Pierre-Louis, P.A.; Decision and Order
Document Number: 2025-02339
Type: Notice
Date: 2025-02-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Document Number: 2025-02013
Type: Notice
Date: 2025-01-31
Agency: Drug Enforcement Administration, Department of Justice
Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry
Document Number: 2025-02008
Type: Notice
Date: 2025-01-31
Agency: Drug Enforcement Administration, Department of Justice
Organic Consultants LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare
Document Number: 2025-02014
Type: Notice
Date: 2025-01-31
Agency: Drug Enforcement Administration, Department of Justice
Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.